This content is current only at the time of printing. This document was printed on 4 December 2022. A current copy is located at https://apvma.gov.au/node/67761
Print this page
You are here
Public Release Summary on the evaluation of the new active zilpaterol hydrochloride in the product Zilmax Medicated Premix
At the request of stakeholders, we have extended the consultation closing date to 23 June 2020.